维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Alsinet C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Gene signatures in the management of hepatocellular carcinoma 显示文摘	Hoshida Y Moeini A Alsinet C	2012	Semin Oncol2012，39，4：	1
2	IGF activation in a mo- lecular subclass of hepatocellular carcinoma and pre-clinical effica- cy of IGF-I R blockage 显示文摘	Tovar V Alsinet C Villanueva A	2010	J Hepatol2010，52，4：	1
3	IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage显示文摘	Tovar V Alsinet C Villanueva A	2010	J Hepatol2010，52，4：	1
4	Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
5	Wnt - pathway activation in two molecular classes of hepatocellular carcinoma and experi- mental modulation by sorafenib 显示文摘	J Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
6	Wnt-pathway activation intwo molecular classes of hepatocellular carcinoma and experimentalmodulation by sorafenib 显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
7	VEGF signaling in cancer treatment 显示文摘	Sia D Alsinet C Newell P	2014	Curr Pharm Des2014，20，17：	1
8	Wnt-pathway activa- tion in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
9	Wnt-Pathway Activa- tion in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
10	One patient, two le- sions,two oncogenic drivers of gastric cancer显示文摘	Alsinet C Ranzani M Adams DJ	2014	Genome Biol2014，15，8：	1
11	Molecular approaches to treatment of hepatocellular carcinoma 显示文摘	Lachenmayer A Alsinet C hang CY Llovet JM	2010	Dig Liver Dis2010，42，3：	1
12	VEGF signaling in cancer treat- ment显示文摘	Sia D Alsinet C Newell P	2014	Curr Pharml Des2014，20，17：	1
13	VEGF signaling in cancer treatment 显示文摘	Sia D Alsinet C Newell P	2014	Curr Pharml Des2014，20，17：	1
14	Disruption of IGF sig-nailing in early hepatocellular carcinoma and preclinical efficacy of anti-IGFR-1 blocking therapies显示文摘	Tovar V Alsinet C Sole M	2008	J Hepatol2008，48，2：	1
15	Gene signatures in the management of hepatocellular carcinmna 显示文摘	Hoshida Y Moeini A Alsinet C	2012	Semin Oncol2012，39，4：	1
16	Molecular approaches to treatment of hepatocellular carcinoma 显示文摘	Lachenmayer A Alsinet C Chang CY	2010	Dig Liver Dis2010，423，：	1
17	Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib显示文摘	Lachenmayer A Alsinet C SavicR	2012	Clin Cancer Res2012，18，18：	1
18	Molecular ap- proaches to treatment of hepatocellular carcinoma 显示文摘	Lachenmayer A Alsinet C Chang CY	2010	Dig liver Dis2010，42，3：	1
19	Wnt-pathway activation intwo molecular classes of hepatocellular carcinoma and experimentalmodulation by sorafenib 显示文摘	Lachenmayer A Alsinet C Savic R	2012	Clin Cancer Res2012，18，18：	1
20	Molecular approaches totreatment of hepatocellular carcinoma显示文摘	Lachenmayer A Alsinet C Chang CY	2010	Dig Liver Dis2010，423，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示